Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$449.52NASDAQ Previous Close - Last Trade as of 4:00PM ET 3/27/20

Today's Change-2.78(0.61%)
Bid (Size)$451.01 (1)
Ask (Size)$455.00 (1)
Day Low / High$445.15 - 465.79
Volume1.1 M
 

View Biotechnology IndustryPeer Comparison as of 03/27/2020

 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $449.52
Change: -2.78 (0.61%)
Volume: 1.1 M
4:00PM ET 3/27/2020
 
 

Biogen Inc ( NASDAQ )

Price: $296.75
Change: -8.19 (2.69%)
Volume: 1.7 M
3:59PM ET 3/27/2020
 
 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $217.24
Change: -7.25 (3.23%)
Volume: 1.7 M
4:00PM ET 3/27/2020
 
 

Illumina Inc ( NASDAQ )

Price: $269.05
Change: -5.37 (1.96%)
Volume: 1.4 M
4:00PM ET 3/27/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

2020 Earnings Estimate for Regeneron Pharmaceuticals Reduced
1:20PM ET 3/28/2020 MT Newswires

2020`s forecasted earnings estimate for Regeneron Pharmaceuticals Inc (NASDAQ:REGN, Recent Price: 449.52) for the year ending December 31, 2020 has been...

Analysts Lower Regeneron Pharmaceuticals' Q1, 2020, and 2021 Earnings Forecasts
10:05AM ET 3/25/2020 MT Newswires

Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 449.53) consensus forecasts for Q1 ending March 31, 2020, and the full year estimates for 2020...

Regeneron Accelerates Timeline For COVID-19 Treatment Trial to Early Summer as Drugmakers Work to Find Vaccine
2:05PM ET 3/17/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) shares surged Tuesday on the biotech company's plan to start soon human clinical trials of a COVID-19 treatment, with the...

US Stocks Bounce With Utilities Leading Gains; Mnuchin Unveils Plan to Cushion Coronavirus Impact; Fed Eases Strains in Commercial Paper Market
1:53PM ET 3/17/2020 MT Newswires

US stocks bounced with a defensive tone as Treasury Secretary Steven Mnuchin spelled out plans to cushion the impact of the COVID-19 pandemic and the...

View all Commentary and Analysis

Don't Chase The Sugar High
12:48PM ET 3/27/2020 Seeking Alpha

Reviving A Comatose Economy
11:34AM ET 3/26/2020 Seeking Alpha

Healthcare And Biotechnology Dashboard - Update
2:33PM ET 3/24/2020 Seeking Alpha

25 Stocks That Are Holding Up Well
1:55PM ET 3/23/2020 Seeking Alpha

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Phone+1.914.847.7000
Number of Employees7,400
Recent SEC Filing03/11/20204
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Executive VP-Research & DevelopmentNeil Stahl

Company Highlights

Price Open$446.03
Previous Close$452.30
52 Week Range$271.37 - 518.00
Market Capitalization$48.6 B
Shares Outstanding108.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement05/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$17.75
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin26.91%
Return on Equity20.75%

Analyst Ratings as of 02/24/2020

Buy
11
Overweight
2
Hold
12
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset